Viking Therapeutics (VKTX) Shares Issued (2015 - 2026)

Viking Therapeutics (VKTX) has 12 years of Shares Issued data on file, last reported at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 26.43% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 26.43% YoY), and the FY2025 full-year result was $5.1 million, up 8.03% from the prior year.
• Shares Issued declined to $3.8 million in Q1 2026, from $5.1 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $5.8 million in Q1 2023 to a low of $2.4 million in Q2 2023.
• A 5-year average of $4.2 million and a median of $4.9 million in 2024 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued sank 53.79% in 2023 and soared 117.09% in 2024, its largest moves.
• Tracing VKTX's Shares Issued over 5 years: stood at $5.2 million in 2022, then rose by 1.76% to $5.2 million in 2023, then fell by 9.8% to $4.7 million in 2024, then gained by 8.03% to $5.1 million in 2025, then dropped by 25.47% to $3.8 million in 2026.
• Business Quant data shows VKTX's Shares Issued at $3.8 million in Q1 2026, $5.1 million in Q4 2025, and $2.9 million in Q3 2025.